Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: CRPS I, Causalgia
Interventions: Intraspinal-optimal stim therapy; Device
Lead sponsor: Millennium Pain Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Bloomington, Illinois

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Avascular Necrosis, Rheumatoid Arthritis
Interventions: POPOP (preoperative patient optimization program), SOC (standard of care); Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 80 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Type 1 Diabetes
Interventions: Medtronic MiniMed Closed Loop (CL) System, Snacking; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 44 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Deafness; Sensoneural Single Sided, Conductive Hearing Loss, Mixed Hearing Loss
Interventions: Osia System; Device
Lead sponsor: Cochlear; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Brain MRI
Interventions: Brain MRI, Brain MRI - SOC and spiral, Brain MRI - spiral; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2028 – 2031
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Breast Cancer
Interventions: Spectroscopic photoacoustic imaging; Diagnostic Test
Lead sponsor: Geoff Luke; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: 2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease, COVID-19 Pandemic, COVID-19 Virus Disease, COVID-19 Virus Infection, Coronavirus Disease 2019, Coronavirus Disease-19, SARS-CoV-2 Infection
Interventions: Diagnostic Test: Diagnostic Software as Medical Device; Device
Lead sponsor: AudibleHealth AI, Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 514 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Sunrise, Florida

Conditions: Major Depressive Disorder
Interventions: Auricular Acupuncture, Sham Auricular Acupuncture + Lexapro; Device · Drug
Lead sponsor: Florida Gulf Coast University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)
Interventions: Nivolumab, Relatlimab, Ipilimumab; Drug
Lead sponsor: Dan Zandberg; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia, Bipolar I Disorder
Interventions: ERG assessment (RSPA); Device
Lead sponsor: diaMentis Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 11
States / cities: Garden Grove, California • Lemon Grove, California • Torrance, California + 8 more

Conditions: Cardiomyopathies, Primary
Interventions: (18F)Flutemetamol; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stuttering
Interventions: Tactile Stimulation; Device
Lead sponsor: University of Mississippi, Oxford; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 1
States / cities: University, Mississippi

Conditions: Stroke
Interventions: measuring cognitive flexibility including working memory and set-switching; Behavioral
Lead sponsor: Kai Hwang; Other
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stroke, Motor Cortex; Lesion
Interventions: Rasch modified version of the Fugl-Meyer Motor assessment, Anatomical image acquisition, Functional MRI task and acquisition; Diagnostic Test
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Insulin Resistance, Glucose Intolerance, Obesity, Atherosclerosis
Interventions: Reactive hyperemia peripheral artery tonometry (Rh-PAT), Blood levels for glucose, insulin, lipids and adipocytokines; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 12 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Lung Cancer, Non-small Cell Lung Cancer (NSCLC)
Interventions: Dasatinib - 1A, Afatinib - 1A, Dasatinib - 1B, Afatinib - 1B; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Attention-Deficit/Hyperactivity Disorder
Interventions: Neurofeedback treatment; Device
Lead sponsor: Ohio State University; Other
Eligibility: 7 Years to 10 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: Asheville, North Carolina • Columbus, Ohio

Conditions: Migraine
Interventions: Stimulation of the Occipital Nerves; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 8 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 4
States / cities: Newington, New Hampshire • New York, New York • Cincinnati, Ohio + 1 more

Conditions: Voiding Disorders
Interventions: Simultaneous functional MRI and urodynamic studies, Questionnaires, Post Void Residual (PVR), Uroflow and Bladder Diary, Urinalysis; Diagnostic Test · Behavioral · Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 45 Years to 90 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Adiposity
Interventions: Exercise; Other
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Surface functional electrical stimulation (FES), Motor learning, Brain computer interface (BCI) training; Other
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 22 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Eye Movements, Attention, Executive Function
Interventions: Contour Search Task, Stop signal Task, Useful field of View, Attentional capture search task; Other · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Colorectal Cancer
Interventions: Guardant SHIELD blood-based colorectal cancer screening test; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 297 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Critical Limb Ischemia
Interventions: FlowMet; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Trialing of ISS in Patients With CRPS

Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA

Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop

Clinical Performance of a New Implant System for Bone Conduction Hearing

The Spiral MRI Study

Photoacoustic Lymph Node Imaging

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

ERG Components in Schizophrenia and Bipolar Disorder Type I

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

The Effects of Tactile Speech Feedback on Stuttering Frequency

Cognitive Control Functions of the Human Thalamus

Imaging Laterality in Chronic Stroke Patients

Endothelial Function in Obese Adolescents

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

Occipital Nerve Stimulation in the Treatment of Migraine

Brain Imaging in Men With Lower Urinary Tract Symptoms

Myokine Identification Following Acute Exercise

Non-Invasive Brain Signal Training to Induce Motor Control Recovery After Stroke

An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans

Understanding Patient Preference on Colorectal Cancer Screening Options

Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI)